Shirley Rheinfelder, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3149 N Windsong Dr, Prescott Valley, AZ 86314 Phone: 928-445-6083 Fax: 928-775-2307 |
Victoria C Valdecanas, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7700 E Florentine Rd Ste 202, Prescott Valley, AZ 86314 Phone: 928-442-8710 Fax: 928-442-8742 |
Klaus P Appel, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 7700 E Florentine Rd, Prescott Valley, AZ 86314 Phone: 928-442-8710 Fax: 928-442-8742 |
Bethany L Luce, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 3251 N Windsong Dr, Prescott Valley, AZ 86314 Phone: 928-772-2582 Fax: 928-772-2383 |
Dr. George E. Dean, M. D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7700 E Florentine Rd Ste 202, Prescott Valley, AZ 86314 Phone: 928-442-8710 Fax: 928-442-8642 |
Thomas F. Garland, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 3380 N Windsong Dr, Prescott Valley, AZ 86314 Phone: 602-789-0344 |
Dr. Ritu Gothwal, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3262 N Windsong Dr, Prescott Valley, AZ 86314 Phone: 928-771-4788 Fax: 928-771-5712 |
Ellen V Lorenz, CFNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3221 N Windsong Dr, Prescott Valley, AZ 86314 Phone: 928-910-7010 Fax: 928-910-7011 |
Mr. Anthony Joseph Brown, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7700 E Florentine Rd Ste 101, Prescott Valley, AZ 86314 Phone: 928-442-8710 Fax: 928-442-8742 |
Christine S Bohannan, NP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3251 N Windsong Dr, Prescott Valley, AZ 86314 Phone: 928-772-2582 Fax: 877-319-1729 |
News Archive
Brookdale Senior Living Inc. announced today that the Company has obtained a $117.0 million first mortgage loan from Berkadia Commerical Mortgage and Fannie Mae. The mortgage debt has a 10 year term and bears interest at a fixed rate of 5.98%. The Company simultaneously repaid $119.0 million of mortgage debt which was scheduled to mature in 2011. The new mortgage debt is secured by four previously unencumbered communities and 15 of 22 communities that previously served as collateral for the loans that were repaid.
Repros Therapeutics Inc. today announced that the Company has received verbal confirmation from the Division of Metabolic and Endocrine Drug Products of the Food and Drug Agency that the Company may initiate its Investigational New Drug Application for the study of oral Androxal® in the treatment of hypogonadal men with Type II Diabetes (T2D) with a Phase IIa trial.
Epidemiologist David Larsen, from Syracuse University and microbiologists Hyatt Green, from the College of Environmental Science and Forestry and Frank Middleton, from Upstate Medical University are lead members of a multi-institution research project that is expected to have global application in future efforts to track and contain Sudden Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus Disease 2019 (COVID-19).
4SC AG, the German drug discovery and development company, today announced the dosing of the first patient in its Phase II trial with 4SC-201 (resminostat), a pan-histone deacetylase (HDAC) inhibitor, as a new potential treatment option for patients with advanced hepatocellular carcinoma (HCC), the most frequent form of liver cancer.
ERT, a leading provider of centralized services to global pharmaceutical, biotechnology and medical device companies, announces a pioneering electronic self-rated version of the Columbia Suicide Severity Rating Scale (C-SSRS) to facilitate compliance with regulatory requirements for prospective monitoring of suicidal ideation and behaviors.
› Verified 9 days ago